Beatrice Lupsa, MD
Assistant Professor of Medicine (Endocrinology)Cards
About
Research
Publications
2022
Ketones: the double-edged sword of SGLT2 inhibitors?
Lupsa BC, Kibbey RG, Inzucchi SE. Ketones: the double-edged sword of SGLT2 inhibitors? Diabetologia 2022, 66: 23-32. PMID: 36255460, DOI: 10.1007/s00125-022-05815-1.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsSGLT2 inhibitorsDrug categoriesSodium-glucose cotransporter 2 inhibitorsCardio-renal benefitsNormal blood glucose concentrationsCotransporter 2 inhibitorsClasses of medicationsAnti-inflammatory effectsSerious adverse effectsType 1 diabetesBlood glucose levelsBlood glucose concentrationKidney outcomesRare complicationBlood pressureSGLT2 inhibitionGlucose levelsKetone levelsBody weightType 2Ketone bodiesAdverse effectsGlucose concentrationInhibitorsEdged sword
2021
Continuous Glucose Monitoring for the Internist
Lee GS, Lupsa BC. Continuous Glucose Monitoring for the Internist. Medical Clinics Of North America 2021, 105: 967-982. PMID: 34688421, DOI: 10.1016/j.mcna.2021.06.004.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsContinuous glucose monitoringContinuous glucose monitoring systemDiabetes mellitusGlucose monitoring systemGlucose monitoringGlycemic patternsType 2 diabetes mellitusType 1 diabetes mellitusTreatment regimenDiabetes careGlucose readingsHemoglobin AGlucose dataMellitusPatientsInterstitial fluidConvenient wearable devicesCorticosteroid use in chronic dermatologic disorders and osteoporosis
Lupsa BC, Insogna KL, Micheletti RG, Caplan A. Corticosteroid use in chronic dermatologic disorders and osteoporosis. International Journal Of Women's Dermatology 2021, 7: 545-551. PMID: 35024411, PMCID: PMC8721058, DOI: 10.1016/j.ijwd.2021.07.014.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsGlucocorticoid-induced osteoporosisGlucocorticoid therapyChronic dermatologic disordersUse of glucocorticoidsSerious side effectsGlucocorticoid useCorticosteroid useBone healthBone lossDermatologic disordersSide effectsPatientsOsteoporosisGlucocorticoidsTherapyCase vignettesRiskComplicationsDermatologistsDiabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome
Lupsa B, Inzucchi S. Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome. Contemporary Endocrinology 2021, 9-25. DOI: 10.1007/978-3-030-67455-7_2.ChaptersHyperosmolar hyperglycemic syndromeDiabetic ketoacidosisAcute complicationsHyperglycemic syndromeAnion gap metabolic acidosisSerious acute complicationsGap metabolic acidosisAppropriate clinical careImmediate medical attentionMetabolic acidosisExtreme hyperglycemiaMedical attentionClinical careSevere dehydrationHealthcare providersPatientsKetoacidosisComplicationsHyperglycemiaSyndromeDiabetesKetonemiaPathophysiologyAcidosisDiagnosisGoodman’s Basic Medical Endocrinology book, 5th edition
Holt E, Lupsa B, Lee G, Bassyouni H, Peery H.BooksDiabetic Ketoacidosis & Hyperosmolar Hyperglycemic Syndrome
Endocrine Emergencies: Recognition and Treatment book, second edition Co-author with Dr. Silvio InzucchiChaptersOsteoporosis in men
Elsevier ClinicalKeyChapters
2019
Personalized Management of Type 2 Diabetes
Peter PR, Lupsa BC. Personalized Management of Type 2 Diabetes. Current Diabetes Reports 2019, 19: 115. PMID: 31686226, DOI: 10.1007/s11892-019-1244-0.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsType 2 diabetesManagement of patientsUnique patient characteristicsSpecific patient subpopulationsClass of agentsGlycemic targetsTreatment landscapeMedical therapyPatient characteristicsPharmacotherapeutic optionsPatient subpopulationsIndividualized carePersonalized managementClinical practiceType 2ReviewOur goalRecent FindingsWePatientsDiabetesTherapyManagementPhysiciansCareClinical Presentation, Diagnosis and Initial Evaluation of Diabetes Mellitus in Adults
Inzucchi SI, Lupsa BC, Clinical Presentation, Diagnosis and Initial Evaluation of Diabetes Mellitus in Adults, chapter in UpToDateChapters
2018
Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits
Lupsa BC, Inzucchi SE. Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits. Diabetologia 2018, 61: 2118-2125. PMID: 30132031, DOI: 10.1007/s00125-018-4663-6.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH KeywordsBenzhydryl CompoundsBlood GlucoseBlood PressureBody WeightBone and BonesCanagliflozinCardiovascular DiseasesDiabetes Mellitus, Type 2Diabetic KetoacidosisGlucosidesHumansHypoglycemic AgentsKetosisKidneyNeoplasmsRandomized Controlled Trials as TopicRisk AssessmentSodium-Glucose Transporter 2Sodium-Glucose Transporter 2 InhibitorsWeight LossConceptsSGLT2 inhibitorsSodium-glucose cotransporter 2 inhibitorsPostprandial blood glucose levelsEuglycaemic diabetic ketoacidosisGlucose-lowering medicationsCotransporter 2 inhibitorsDiabetic kidney diseaseGenitourinary tract infectionsLower extremity amputationHigh-risk individualsBlood glucose levelsPlasma glucose concentrationCardiovascular outcomesDiabetic ketoacidosisUrinary frequencyTract infectionsOptimal prescribingNew drug categoryKidney diseaseGlucose reabsorptionGlucose levelsHigh riskDrug categoriesBody weightBone fractures
Academic Achievements & Community Involvement
Clinical Care
Overview
Beatrice C. Lupsa, MD, is an endocrinologist who specializes in type 1 and type 2 diabetes. “I understand that living with diabetes presents you with challenges, and I want to help you overcome these challenges,” she tells new patients. “I will work with you to better understand your individual treatment concerns and provide you with the best clinical outcomes possible.”
She is deeply committed to helping diabetics manage their disease. The Yale Medicine Diabetes Center offers superior diabetes care, with such cutting-edge devices as glucose monitors and insulin pumps for more complicated cases, she says. She collaborates with an experienced team of nurse practitioners and dieticians who are trained to treat diabetes. “Medical and educational management of diabetes go hand in hand,” Dr. Lupsa says. “Our practice provides state-of-the-art care utilizing new options to treat the disease.”
She is an assistant professor of medicine (endocrinology) at Yale School of Medicine.
Clinical Specialties
Endocrinology
Board Certifications
Endocrinology Diabetes & Metabolism
- Certification Organization
- AB of Internal Medicine
- Latest Certification Date
- 2019
- Original Certification Date
- 2009
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Latest Certification Date
- 2017
- Original Certification Date
- 2007
News
Get In Touch
Contacts
Appointment Number
Clinic Fax Number
Administrative Support
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
Events
Apr 20253Thursday
- Yale OnlyFaith Danielle Crittenden, MD, MPH
Apr 202517Thursday
- Yale OnlyPriyadarshini Balasubramanian, MD
May 20251Thursday
- Yale Only
May 202515Thursday
- Yale Only